Cryptococcosis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2026

The global cryptococcosis market is expected to grow at a steady CAGR of 5.70% over the period between 2019 and 2026. Moreover, the global market registered a total revenue of US$4.72 bn in 2017 and this figure is expected to elevate to US$7.8 bn by 2026-end.

The report analyzes and forecasts the Cryptococcosis market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.

This report first introduces the background of Cryptococcosis, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Cryptococcosis companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Cryptococcosis upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of Cryptococcosis and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Cryptococcosis market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the Cryptococcosis market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The report provides size (in terms of volume and value) of Cryptococcosis market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

Competitive Landscape

The report also profiles major players in the global cryptococcosis market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Bristol-Myers Squibb Company, Janssen Biotech, Inc. (Johnson & Johnson), Abbott Laboratories, Novartis AG, Pfizer, Inc., Valeant Pharmaceuticals, Inc., Glenmark Pharmaceuticals and Sigmapharm Laboratories LLC.

The global cryptococcosis market has been segmented as given below:

Global Cryptococcosis Market, by Treatment,

  • Amphotericin B
    • Amphocin
    • Fungizone
    • Other
  • Flucytosine
    • Ancobon
    • Other
  • Fluconazole
    • Diflucan
    • Other
  • Others (Voriconazole, surgery treatment, etc.)

Global Cryptococcosis Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Store
  • Mail Order Pharmacies
  • Other

Global Cryptococcosis market, by Region

  • North America
    • U.S.
    • Canada
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.

Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

The study objectives of this report are:

  • To analyze and study the global Cryptococcosis capacity, production, value(revenue), growth rate (CAGR), market share, historical, consumption, status (2014-2018) and forecast (2019-2026)
  • Market value USD Million and volume Units Million data for each segment and sub-segment
  • Focuses on the key Cryptococcosis manufacturers, to study the capacity, production, value, market share and development plans in future
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Acronyms Used
2.3. Research Methodology

3. Executive Summary
3.1. Global Cryptococcosis Market Snapshot

4. Market Overview
4.1. Product Overview
4.2. Market Indicators
4.3. Global Cryptococcosis Market Size (US$ Mn) Forecast, 2014–2026
4.4. Global Cryptococcosis Market Outlook
4.5. Key Industry Events
4.6. Global Cryptococcosis Incidence Scenario-2015, by Region
4.7. Overview of Clinical Trials

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Increasing incidence of cryptococcosis infections
5.2.2. Rising initiatives by government and non-government organizations
5.2.3. Impetus from HIV patients
5.2.4. Improved access to diagnostic facilities
5.3. Restraints
5.3.1. High mortality among cryptococcosis infected patients
5.3.2. Patent expiry of key drugs and entry of generics
5.4. Opportunity Analysis
5.5. Opportunities
5.5.1. Setting up integrated facilities in high-potential markets
5.5.2. Investment inflow and mergers & acquisitions

6. Global Cryptococcosis Market Analysis, by Treatment
6.1. Introduction
6.2. Key Findings
6.3. Global Cryptococcosis Market Value Share Analysis, by Treatment, 2016-2026
6.3.1. Amphotericin B
6.3.2. Flucytosine
6.3.3. Fluconazole
6.3.4. Others (Voriconazole, surgery treatment, etc.)
6.4. Global Cryptococcosis Market Attractiveness Analysis, by Treatment, 2014–2026
6.5. Key Trends

7. Global Cryptococcosis market Analysis, by Distribution Channel
7.1. Introduction
7.2. Key Findings
7.3. Global Cryptococcosis Market Value Share Analysis, by Distribution Channel, 2016 -2026
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Drug Store
7.3.4. Mail Order Pharmacies
7.3.5. Others
7.4. Cryptococcosis Market Attractiveness Analysis, by Distribution Channel, 2014-2026
7.5. Key Trends

8. Global Cryptococcosis Market Analysis, by Region
8.1. Global Market Scenario by Country
8.2. Global Cryptococcosis Market Value Share Analysis, by Region, 2016 and 2026

9. North America Cryptococcosis Market Analysis
9.1. Key Findings
9.2. Market Overview
9.3. North America Cryptococcosis Market Value Share Analysis, by Country
9.4. North America Cryptococcosis Market Value Share Analysis, by Treatment
9.5. North America Cryptococcosis Market Value Share Analysis, by Distribution Channel
9.6. North America Cryptococcosis Market Attractiveness Analysis
9.7. Key Trends

10. Middle East & Africa Cryptococcosis Market Analysis
10.1. Key Findings
10.2. Market Overview
10.3. Middle East & Africa Cryptococcosis Market Value Share Analysis, by Country
10.4. Middle East & Africa Cryptococcosis Market Value Share Analysis, by Treatment
10.5. Middle East & Africa Cryptococcosis Market Value Share Analysis, by Distribution Channel
10.6. Middle East & Africa Cryptococcosis Market Attractiveness Analysis
10.7. Key Trends

11. Asia Pacific Cryptococcosis Market Analysis
11.1. Key Findings
11.2. Asia Pacific Cryptococcosis Market Overview
11.3. Asia Pacific Cryptococcosis Market Value Share Analysis, by Country
11.4. Asia Pacific Cryptococcosis Market Value Share Analysis, by Treatment
11.5. Asia Pacific Cryptococcosis Market Value Share Analysis, by Distribution Channel
11.6. Asia Pacific Cryptococcosis Market Attractiveness Analysis
11.7. Key Trends

12. Europe Cryptococcosis market Analysis
12.1. Key Findings
12.2. Market Overview
12.3. Europe Cryptococcosis Market Value Share Analysis, by Country
12.4. Europe Cryptococcosis Market Value Share Analysis, by Treatment
12.5. Europe Cryptococcosis Market Value Share Analysis, by Distribution Channel
12.6. Europe Cryptococcosis Market Attractiveness Analysis
12.7. Key Trends

13. Latin America Cryptococcosis market Analysis
13.1. Key Findings
13.2. Market Overview
13.3. Latin America Cryptococcosis Market Value Share Analysis, by Country
13.4. Latin America Cryptococcosis Market Value Share Analysis, by Treatment
13.5. Latin America Cryptococcosis Market Value Share Analysis, by Distribution Channel
13.6. Latin America Cryptococcosis Market Attractiveness Analysis
13.7. Key Trends

14. Competition Landscape
14.1. Cryptococcosis Market Share Analysis By Company, 2016 (Estimated)
14.2. Competition Matrix
14.3. Company Profiles
14.3.1. Bristol-Myers Squibb Company
14.3.1.1. Company Details
14.3.1.2. Business Overview
14.3.1.3. Financial Overview
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.2. Janssen Biotech, Inc. (Johnson & Johnson)
14.3.2.1. Company Details
14.3.2.2. Business Overview
14.3.2.3. Financial Overview
14.3.2.4. Strategic Overview
14.3.2.5. SWOT Analysis
14.3.3. Abbott Laboratories
14.3.3.1. Company Details
14.3.3.2. Business Overview
14.3.3.3. Financial Overview
14.3.3.4. Strategic Overview
14.3.3.5. SWOT Analysis
14.3.4. Novartis AG
14.3.4.1. Company Details
14.3.4.2. Business Overview
14.3.4.3. Financial Overview
14.3.4.4. Strategic Overview
14.3.4.5. SWOT Analysis
14.3.5. Pfizer, Inc.
14.3.5.1. Company Details
14.3.5.2. Business Overview
14.3.5.3. Financial Overview
14.3.5.4. Strategic Overview
14.3.5.5. SWOT Analysis
14.3.6. Valeant Pharmaceuticals, Inc.
14.3.6.1. Company Details
14.3.6.2. Business Overview
14.3.6.3. Financial Overview
14.3.6.4. Strategic Overview
14.3.6.5. SWOT Analysis
14.3.7. Glenmark Pharmaceuticals
14.3.7.1. Company Details
14.3.7.2. Business Overview
14.3.7.3. Financial Overview
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.8. Viamet Pharmaceuticals, Inc.
14.3.8.1. Company Details
14.3.8.2. Business Overview
14.3.8.3. Financial Overview
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.9. Sigmapharm Laboratories LLC
14.3.9.1. Company Details
14.3.9.2. Business Overview
14.3.9.3. Financial Overview
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers